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The β-barrel assembly machinery (BAM) inserts outer membrane β-barrel proteins 21 
(OMPs) in the outer membrane of Gram-negative bacteria. In Enterobacteriacea, BAM 22 
also mediates export of the stress sensor lipoprotein RcsF to the cell surface by assembling 23 
RcsF-OMP complexes. Here, we report the crystal structure of the key BAM component 24 
BamA in complex with RcsF. BamA adopts an inward-open conformation, with the 25 
 2 
lateral gate to the membrane closed. RcsF is lodged deep inside the lumen of the BamA 26 
barrel, binding regions proposed to undergo an outward and lateral opening during OMP 27 
insertion. On the basis of our structural and biochemical data, we propose a push-and-28 
pull model for RcsF export upon conformational cycling of BamA and provide a 29 
mechanistic explanation for how RcsF uses its interaction with BamA to detect envelope 30 
stress. Our data also suggest that the flux of incoming OMP substrates is involved in the 31 




The vast majority of proteins inserted in the outer membrane of Gram-negative bacteria adopt 36 
a β-barrel conformation. Their assembly depends on the activity of the conserved β-barrel 37 
assembly machinery (BAM), whose core component is the OMP85-family protein BamA 1,2. 38 
BamA is an outer membrane 16-stranded β-barrel with a large periplasmic extension consisting 39 
of five POlypeptide TRansport-Associated (POTRA) domains at its N-terminus 1. Structures 40 
of BAM have shown that BamA can adopt two conformations: an outward-open conformation 41 
3,4, in which the β-barrel domain opens between strands β1 and β16 to form a lateral gate to the 42 
membrane, and an inward-open conformation 5,6, in which the lateral gate is sealed while a 43 
periplasmic entry pore to the barrel lumen is open. In the bacterium Escherichia coli, four 44 
accessory lipoproteins (BamB, BamC, BamD, and BamE) complete BAM, forming a 45 
pentameric holocomplex 7,8. BamBCDE are anchored to the outer membrane by a lipid moiety 46 
but reside in the periplasm. BamB and BamD directly bind the POTRA domains of BamA, 47 
while BamC and BamE bind BamD 1,2. Although all components are required for efficient 48 
assembly of E. coli’s diverse set of OMPs, only BamA and BamD are essential and conserved 49 
throughout Gram-negative bacteria 1,2. Despite important structural and functional insights 50 
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during 15 years of intense scrutiny due to the essential activity of BAM in generating and 51 
maintaining the outer membrane, crucial questions remain unsolved regarding the mechanism 52 
of this molecular machine. In particular, the functional importance of BamA cycling between 53 
the outward-open and inward-open conformations remains unclear, as are the respective 54 
contributions of the various BAM components to OMP assembly 9. 55 
 56 
The primary function of BAM is the assembly of OMPs and, when necessary, the translocation 57 
of their associated extracellular domains across the outer membrane. More recently, BAM has 58 
also been implicated in export of the outer membrane lipoprotein RcsF to the cell surface 10,11 59 
via the assembly of complexes between this lipoprotein and three abundant OMPs (OmpA, 60 
OmpC, and OmpF) 10,11. Support for the involvement of BAM in RcsF export comes from in 61 
vivo crosslinking experiments in which a complex between RcsF and BamA, considered to be 62 
an intermediate in the formation of RcsF-OmpA/C/F complexes, was trapped 10,11. Further, in 63 
cells lacking BamB and BamE, RcsF accumulates on BamA and causes a lethal block to BAM-64 
mediated OMP assembly, suggesting that OMPs and surface-exposed RcsF exploit at least 65 
partially overlapping assembly routes 12,13. 66 
 67 
RcsF functions as an envelope stress sensor capable of mounting a protective response when 68 
damage occurs in the peptidoglycan or in the outer membrane 14,15. Interestingly, we previously 69 
determined that sending RcsF to the surface is part of a cellular strategy that enables RcsF to 70 
detect damage in the cell envelope. Under stress conditions, newly synthesized RcsF molecules 71 
fail to interact with BamA 10: they are not exported to the surface and remain exposed to the 72 
periplasm, which allows them to trigger the Rcs signaling cascade by reaching the downstream 73 
Rcs partner in the inner membrane 16. Thus, surface exposure is intimately linked to the 74 
function of RcsF. However, the molecular details of the BamA-RcsF interaction, how BAM 75 
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orchestrates the export of RcsF with OMP assembly, and what prevents RcsF from interacting 76 
with BamA under stress conditions remain unknown. Here we sought to address these 77 




RcsF can be purified with the BAM complex 82 
In a series of exploratory experiments, we co-overexpressed RcsF with the BamAB sub-83 
complex, or with the BamABCDE holocomplex; both BamAB-RcsF and BamABCDE-RcsF 84 
could be detergent-extracted from the membrane and purified via affinity chromatography 85 
using a His-tag on the N-terminus of BamA (Fig. 1a). Using native gel electrophoresis, we 86 
confirmed that RcsF binds BamABCDE, and not only BamAB (Fig. 1a, b, c). However, 87 
whereas BamAB-RcsF was stable and could be purified to homogeneity by size-exclusion 88 
chromatography, BamABCDE-RcsF was unstable (Extended Data Fig. 1a, b). Interesting to 89 
note, destabilization of BamABCDE was only observed when RcsF was present (Extended 90 
Data Fig. 1c).  91 
 92 
BamA is in the inward-open conformation in the structure 93 
The BamAB-RcsF complex was crystallized and its structure solved to 3.8 Å resolution by 94 
molecular replacement using the structures of BamA and RcsF (PDB: 5D0O and 2Y1B, 95 
respectively; Supplementary Table 1). While this structure contained BamA and RcsF (Fig. 2), 96 
BamB dissociated from the BamA-RcsF complex during crystallization and was absent. The 97 
asymmetric unit contained two BamA-RcsF conformers, although for one of them, no 98 
unambiguous electron density was observed for POTRA domains 1, 2, 3, and 5 (Extended Data 99 
Fig. 2a, b). The β-barrel of BamA was found in an inward-open conformation closely matching 100 
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that reported in structures of E. coli BamABCDE (6, with a root mean square deviation of 0.9 101 
Å for 383 equivalent Cα atoms in the BamA β-barrel of PDB: 5D0O) or BamA truncates 102 
lacking POTRA domains 1-4 or 1-5 17-20.  103 
 104 
RcsF is located inside the lumen of the BamA β-barrel 105 
In both BamA copies, RcsF was lodged deep inside the lumen of the BamA β-barrel (Fig. 2a; 106 
Extended Data Fig. 2c). RcsF contacts two BamA loops protruding into the β-barrel: (1) 107 
extracellular loop L6 (eL6; ~77 Å2 buried surface area, one putative H bond; note that at 3.8 Å 108 
resolution, amino-acid sidechain positions cannot be unambiguously determined), and (2) the 109 
periplasmic loop connecting strands 7 and 8 (pL4; ~140 Å2 buried surface area, one putative H 110 
bond) (Fig. 2, 3a). Although contacting RcsF, these loops retain a conformation closely 111 
matching that seen in inward-open BamA structures (Fig. 3b). However, the main BamA-RcsF 112 
contact occurs through the luminal wall of the BamA β-barrel, encompassing ~1100 Å2 of 113 
buried surface area and comprising up to 15 putative H-bonds (Fig. 2). This RcsF-BamA β-114 
barrel interaction can be divided into three zones. Zone 1 (Z1) consists of perhaps nine H bonds 115 
formed by BamA residue 488 and residues 463, 465, and 466 in the loop connecting β3 and β4 116 
and contacting the RcsF loop connecting β1 and α1 (Lβ1-α1) (Fig. 2b, c, Fig. 3a, c). Zone 2 (Z2) 117 
is made of perhaps four H bonds formed by BamA residues 592 and 634, located above pL4 118 
(Fig. 2c, 3a). β16, one of the components of the proposed lateral gate of the BamA β-barrel, 119 
constitutes the third zone (Fig. 2b, c, 3a). The bottom of RcsF protrudes out of the BamA β-120 
barrel into the periplasm, residing in close proximity to POTRA domains 3-5 (Fig. 2a, b). As 121 
a result, RcsF sterically pushes POTRA5 outward, causing a 26° rotation compared to the 122 
inward-open conformation found in BamA structures 5,6 (Fig. 3b). Although the lipid anchor 123 
of RcsF and the N-terminal disordered linker (residues 16-50) 21,22 are not apparent in this 124 
structure, the position of RcsF is compatible with the lipid anchor residing in the inner leaflet 125 
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of the outer membrane. Of note, the binding interface between RcsF and BamA does not 126 
overlap with the binding sites of BamA for its accessory lipoproteins (Extended Data Fig. 3). 127 
Consistent with this observation, the RcsF-BamA interaction is compatible with the binding of 128 
BamBCDE, as determined experimentally (Fig. 1; Extended Data Fig. 1). 129 
 130 
To validate the BamA-RcsF conformation revealed by the X-ray structure, we subjected the 131 
complex to crosslinking and analysis via mass spectrometry using the homobifunctional NHS-132 
ester crosslinker disuccinimidyl dibutyric urea 23. The sequence coverage of RcsF was about 133 
60% (Extended Data Fig. 4a). Note that one peptide from the N-terminal linker was detected, 134 
indicating that the N-terminal disordered region was not degraded during purification.  135 
Crosslinks were identified between lysine residues in RcsF (two lysines from the globular 136 
domain and one located at the C-terminus of the linker) and those in POTRA4 and POTRA5 137 
(Extended Data Fig. 4b; Supplementary Table 2), providing further support for the architecture 138 
of BamA-RcsF determined by crystallography. To confirm that RcsF binds inside the barrel of 139 
BamA, we incorporated the photoreactive lysine analog N6-((3-(3-methyl-3H-diazirin-3-140 
yl)propyl)carbamoyl)-L-lysine (DiZPK) 24 at multiple positions in the BamA β-barrel domain, 141 
selecting residues (R583, R592, K598, K610, R632, R634, R661, K808) whose sidechains face 142 
the lumen of the barrel (Extended Data Fig. 4b). After exposure to ultraviolet light, RcsF 143 
efficiently crosslinked to BamA when DiZPK was incorporated at three of the selected residues 144 
(R592, R598, K610) and to a lower extent at residue K808 (Extended Data Fig. 4b, c), 145 
confirming that RcsF binds deep inside the barrel. We measured an equilibrium dissociation 146 
constant of 350±49 or 420±48 nM, respectively, depending on whether BamA or RcsF was 147 
immobilized (Extended Data Fig. 4d, e). Finally, we deleted loop 1, a short, non-essential 25 148 
segment located between the first and second β-strands of the barrel (residues 434 to 437; 149 
BamA∆loop1) (Fig. 3a; Extended Data Fig. 4b). BamA∆loop1 is functional 5 and able to rescue the 150 
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lethality of a ∆bamA deletion mutant, despite the fact that the levels of major OMPs are slightly 151 
decreased in cells expressing BamA∆loop1 (Extended Data Fig. 4f). We hypothesized that 152 
deleting this loop would destabilize the BamA-RcsF interaction because of the close proximity 153 
of loop 1 to the lateral gate area and to loop 6, two regions of interaction between BamA and 154 
RcsF. As predicted, RcsF could be pulled down with BamA but not with BamA∆loop1 (Extended 155 
Data Fig. 4g). Further, the Rcs signaling cascade, which is turned on when RcsF fails to interact 156 
with BamA 10, was constitutively induced in ∆bamA cells complemented with BamA∆loop1 157 
(Extended Data Fig. 4h). In sum, these results provide functional evidence for our structure of 158 
BamA-RcsF and confirm the presence of RcsF inside the barrel of BamA. 159 
 160 
RcsF does not bind BamA when the lateral gate is open 161 
Strikingly, our structure suggests that RcsF binding is incompatible with the BamA β-barrel 162 
residing in the outward-open conformation (Fig. 3a). Confirming this hypothesis, RcsF was 163 
found to bind BamAG433C/N805C, a mutant in which opening of the lateral gate is prevented by a 164 
disulfide bond between β1 and β16 26, but not to BamAG393C/G584C, which is locked in the 165 
outward-open conformation 5 (Extended Data Fig. 5a, b). However, when reduced, 166 
BamAG393C/G584C returned to the inward-open conformation and regained the ability to bind 167 
RcsF (Extended Data Fig. 5c). Importantly, given its ability to only bind the inward-open 168 
conformation of BamA, the BamA-RcsF complex serves as a proxy for this state. Interestingly, 169 
RcsF was recently reported to accumulate on BamA and to jam OMP assembly in the absence 170 
of BamB and BamE 12,13. Thus, in light of our structural findings, BamA conformational 171 
cycling is likely impaired when BamB and BamE are absent. However, binding of these 172 
accessory lipoproteins cannot be sufficient to trigger conformational changes in BamA. The 173 
structure of BamABCDE has been solved not only in the outward-open conformation but also 174 
in the inward-open conformation 3-6, despite the presence of all accessory lipoproteins. In 175 
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addition, we have shown here that RcsF could be co-purified with BamABCDE (Fig. 1; 176 
Extended Data Fig. 1), implying that in this purified complex, BamA was in the inward-open 177 
conformation. Thus, BamA can remain in the inward-open conformation even when 178 
BamBCDE are present, strongly supporting the notion that BAM conformational cycling is 179 
triggered by an external signal. 180 
 181 
OMP substrates trigger conformational cycling in BamA 182 
What is this trigger? Insights came from in vivo crosslinking experiments carried out in cells 183 
in which the expression levels of the BAM components were only moderately increased (~2-184 
fold) compared with wild-type levels. Whereas RcsF can be crosslinked to BamA when the 185 
BamA and BamB subunits are slightly over-expressed, the BamA-RcsF complex becomes 186 
barely detectable when the moderate over-expression of all BAM components is induced (Fig. 187 
4 a, b). We explain this as follows: the BamAB subcomplex is not functional and does not 188 
funnel RcsF to its OMP partners. As a result, BamA-RcsF accumulates and OmpA-RcsF does 189 
not form (Fig. 4a). However, if all BAM components (BamABCDE) are moderately 190 
overexpressed, BAM activity is restored, RcsF only transiently interacts with BamA, and 191 
formation of OmpA-RcsF resumes (Fig. 4a; note that in these experiments, BAM is still 192 
expressed at physiological levels from the chromosome—by using plasmids, we manipulate 193 
the stoichiometry of the BAM components (Fig. 4b)). Therefore, whether a stable RcsF 194 
complex forms with BAM depends critically on the rates of OMP synthesis and delivery to 195 
BAM, as well as the ratio of active BAM complexes to the concentrations of OMP and RcsF 196 
substrates. When we purified the BamABCDE-RcsF complex (Fig. 1; Extended Data Fig. 1), 197 
all BAM components were highly over-expressed, which increased the ratio of active 198 
complexes to incoming OMP substrates and allowed accumulation of RcsF on BAM. Thus, 199 
our data support a model in which it is the flux of incoming OMP substrates that triggers 200 
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conformational changes in the BamA barrel and release of RcsF to its OMP partners (see 201 
below; Fig. 4c). Although complexes have to date only been observed between RcsF and 202 
OmpA/C/F 10,11, complexes may form between RcsF and other, less abundant OMPs, 203 
depending on the unfolded OMP that is delivered to the BamABCDE-RcsF complex. 204 
 205 
RcsF is transferred to its partners during BamA cycling   206 
RcsF is not an integral component of BAM; it can bind BamA with high affinity, but it is 207 
eventually funneled to OMPs and displayed on the cell surface 10,11. It has been proposed that 208 
RcsF crosses the outer membrane by being threaded through the lumens of OMPs 11. In one 209 
possible scenario, RcsF could be transferred from BamA to its OMP partner following opening 210 
of the lateral gate and formation of a hybrid barrel (or another non-covalent complex 9 between 211 
BamA and the nascent OMP), which then buds away from BamA, taking RcsF with it. 212 
Available structures show that the transition from the inward-open to the outward-open 213 
conformation of BamA encompasses a large outward rotation of strands 1-6 of the BamA β-214 
barrel, as well as a 20 Å inward displacement of POTRA 5 (Fig. 3a, b, c) 5,6. Strikingly, BamA 215 
strands 1-6 coincide with the main RcsF-BamA interaction zone (Z1) seen in our structure, 216 
such that outward rotation of Z1 may exert a pulling force on the tip of RcsF (Fig. 3a, c). 217 
Concomitantly, the inward movement of POTRA5 would exert a pushing force on the bottom 218 
of RcsF (Fig. 3c). We therefore hypothesize that during the inward-to-outward transition of 219 
BamA, this push-and-pull action on RcsF could play a role in the transfer of RcsF to its OMP 220 
partners and its translocation to the cell surface (Fig. 4c). Supporting this, dynamic importance 221 
sampling simulations in which BamA transitions from the inward-open conformation (as in 222 
our structure) to the outward-open conformation (PDB code 5D0Q) show POTRA5 moving 223 
towards the periplasmic exit of the lumen, pushing RcsF upwards. The movement of POTRA5 224 
is accompanied later on by the movement of Z1, opening the outward-facing extremity 225 
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(Extended Data Fig. 6a, b, c, d and Supplementary Video). Furthermore, by introducing a short 226 
peptide in the hinge between POTRA5 and the β-barrel domain of BamA (BamAhinge), we 227 
could confirm the functional importance of this region for BamA activity. We found indeed 228 
that expression of BamAhinge from a plasmid rescues the growth of ∆bamA cells in minimal 229 
media at 30°C but not in rich media at 37°C, indicating that BamAhinge is unable to cope with 230 




Our work reveals how BamA interacts with RcsF, providing insights into the mechanism used 235 
by BAM to assemble RcsF-OMP complexes, a novel activity by which BAM exports this 236 
lipoprotein to the cell surface. It would be surprising if an essential machinery such as BAM—237 
with a global role in formation of the cell envelope—was only dedicated to export RcsF to the 238 
surface. Hence, it is tempting to speculate that other lipoproteins may follow the same route 239 
and decorate the surface of E. coli, in contrast to the general view that outer membrane 240 
lipoproteins face the periplasm 27.  241 
 242 
By showing that the globular domain of RcsF is lodged deep inside the barrel of BamA, our 243 
structure also reveals the remarkable—and unanticipated —finding that the BamA β-barrel can 244 
accommodate a lipoprotein “substrate” with a globular domain 12 kDa in size. This finding 245 
further establishes BAM as an essential hub that contributes to outer membrane biogenesis by 246 
interacting both with nascent OMPs for assembly and lipoproteins for export. Future work will 247 
reveal whether other lipoproteins bind BamA in a way similar to RcsF and also clarify the 248 
topology of the RcsF-OMP complexes. It has indeed been proposed that the lipid moiety of 249 
RcsF is anchored in the outer leaflet of the membrane and that the N-terminal disordered linker 250 
 11 
is exposed on the cell surface before being threaded through the lumens of the OMPs 11. In this 251 
model, the globular domain of RscF resides inside the periplasm. Although we cannot rule out 252 
that RcsF flips during release from BamA and transfer to its OMP partners, our structure is 253 
more consistent with the hypothesis that BamA releases the globular domain of RcsF on the 254 
cell surface. Further investigation will therefore be needed to answer this question, and whether 255 
the location of RcsF depends on the identity of its OMP partner. 256 
 257 
It is also remarkable that RcsF binds the lateral gate area and the outward rotating region of the 258 
BamA barrel, sites that sense BAM conformational cycling triggered by incoming OMP 259 
substrates. We previously reported that RcsF uses its interaction with BamA to detect stress in 260 
the cell envelope: when damage occurs in the peptidoglycan or the outer membrane, newly 261 
synthesized RcsF molecules fail to interact with BamA, activating the Rcs stress response 10. 262 
Our structure provides a possible explanation for this scenario by suggesting that BamA 263 
preferentially adopts the outward-open conformation when envelope integrity is impaired, 264 
which would de facto prevent RcsF binding and promote Rcs activation. Thus, we propose that 265 
cells could monitor envelope integrity via the conformational cycling of BamA. 266 
 267 
How the outer membrane of Gram-negative bacteria is assembled remains a long-standing 268 
mystery and a crucial question in biology. Here, we focused on BamA, the core component of 269 
BAM whose activity is essential to constructing and maintaining the outer membrane. By 270 
solving the structure of BamA in complex with its lipoprotein substrate RcsF, our work sheds 271 
new light on BAM. It not only provides crucial molecular insights into how BAM exports 272 
lipoproteins to the surface, but also uncovers important new features of this essential machinery 273 
and its mechanism. Because BAM activity is required for bacterial survival, the complex is an 274 
attractive target for new antibiotics 28-31.  Our work also paves the way to the design of new 275 
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antibacterials that interfere with BAM conformational cycling, because blocking BAM in the 276 
inward-open conformation lethally jams BAM with RcsF. 277 
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LEGENDS TO THE FIGURES 423 
 424 
Figure 1. RcsF forms a complex with BamAB and BamABCDE. (a, b) SDS-PAGE (a) and 425 
blue native (b) analysis of purified BAM, BAM-RcsF and BamAB-RcsF complexes obtained 426 
via BamA-affinity chromatography. The bands analyzed in (c) are labelled 1 to 8. (c) SDS-427 
PAGE analysis of the complexes shown in panel b (bands 1 to 8). The BAM complex expressed 428 
from pRRA1 is a mixture of BamABCDE and BamABDE. n= 4 biologically independent 429 
experiments. 430 
 431 
Figure 2. Structure of the BamA-RcsF complex. (a) Ribbon diagram of the BamA-RcsF 432 
complex in side view. BamA, gold; RcsF, blue. (b, c) Front (b) and extracellular (c) views of 433 
BamA-RcsF, with RcsF shown as a solvent-accessible surface. POTRA domains 1 and 2 have 434 
been omitted for clarity. BamA eL6, green; pL4, magenta. Putative RcsF-interacting residues 435 
in contact zones Z1 and Z2 of the BamA β-barrel are colored cyan and magenta, respectively, 436 
and shown as sticks. Strands β1 and β16, which form the proposed “lateral gate” of the BamA 437 
β-barrel 1, are yellow. (d) Periplasmic view of the BamA-RcsF complex, with the BamA β-438 
barrel shown as a solvent-accessible surface and RcsF as a ribbon. Colors are as in panels b 439 
and c. POTRA domains were omitted for clarity. 440 
 441 
Figure 3. Conformational characteristics of the BamA-RcsF complex. (a, c) Tilted top view 442 
and slabbed side view of the overlay of the BamA-RcsF complex and BamA in the outward-443 
open conformation (grey, taken from BamACDE complex PDB:5EKQ 4). The BamA β-barrel 444 
undergoes a ~45° outward rotation at strands β1-β6, and a 20 Å inward displacement of 445 
POTRA5 compared to the structure of BamA-RcsF presented here. (b) Slabbed side view of 446 
the overlay of BamA-RcsF and BamA in the inward-open conformation (grey, taken from 447 
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BamABCDE complex PDB:5D0O 5). In the structure of BamA-RcsF presented here, POTRA5 448 
makes a 26° outward rotation relative to R421, where it connects to the BamA β-barrel. (a-c) 449 
Color scheme for BamA-RcsF is as in Fig. 2b. RcsF is shown as a solvent-accessible surface 450 
(a) or a ribbon (b, c). Panels (b, c) show side views, slabbed down to view the interior of the 451 
complex. For 5EKQ and 5D0O, the BAM accessory proteins BamB, C, D, and E were omitted 452 
for clarity, as were POTRA domains 1-4 in all shown BamA structures. 453 
 454 
Figure 4. BamA-RcsF is a proxy for the inward-open conformation of BamA. (a) In vivo 455 
chemical crosslinking of RcsF with BamA and OmpA. The BamA-RcsF complex accumulates 456 
when either BamA alone or BamAB together are moderately over-expressed from a plasmid 457 
in cells also expressing BAM at physiological levels from the chromosome. The copies of 458 
BamA and BamAB in excess are not functional (BamCDE is required for BAM activity) and 459 
do not funnel RcsF to its OMP partners. As a result, RcsF accumulates on BamA and OmpA-460 
RcsF does not form. Over-expression of BamCDE (also from a plasmid) in these cells restores 461 
the stoichiometry between the BAM components: BamA-RcsF does not accumulate and the 462 
formation of OmpA-RcsF is restored. As shown previously 10, levels of OmpA-RcsF are 463 
inversely correlated with BamA-RcsF. Overexpression of the BamCDE sub-complex alone 464 
does not impact the activity of the BAM complex expressed from the chromosome: wild-type 465 
BamA-RcsF and OmpA-RcsF levels are observed. Wild-type BamA-RcsF and OmpA-RcsF 466 
levels are also detected when BamA and BamCDE are overexpressed together, as expected 467 
given that BamB is not essential. RcsF also forms a complex with the abundant lipoprotein Lpp 468 
(Lpp-RcsF), as in 10. Protein expression levels of OmpA were analyzed by immunoblot in the 469 
non-crosslinked samples, showing no differences. The additional bands that are detected in the 470 
lanes where BamA-RcsF is not observed likely correspond to poorly abundant complexes 471 
between RcsF and unknown proteins. n= 3 biologically independent experiments. (b) Protein 472 
 20 
expression levels of BamB, BamC, BamD, BamE and RcsF from no-crosslinked samples 473 
overexpressing BamA (pBamA), BamAB (pBamA-B) and BamCDE (pSC263) were analyzed 474 
by western blot. EF-Tu expression levels were analyzed as loading control. n= 3 biologically 475 
independent experiments. (c) Model proposing that BamA conformational cycling is triggered 476 
by incoming OMP substrates on the BAM holocomplex. A BamA inward-to-outward open 477 
transition could result in an upward displacement of RcsF via a push-and-pull mechanism, 478 
resulting in an OMP-RcsF complex. The push-and-pull mechanism involves BamA POTRA5 479 
(P5) and Z1. The topology of the OMP-RcsF complex remains to be established. For clarity, 480 










































Bacterial strains, plasmids, and primers 486 
Bacterial strains and plasmids used in this study are listed in Supplementary Tables 3 and 487 
4, respectively. The parental E. coli strain DH300 is a MG1655 derivative deleted for the 488 
lac region and carrying a chromosomal rprAP::lacZ fusion at the λ phage attachment site 489 
to monitor Rcs activation 32. To delete bamA on the chromosome, a kanamycin resistance 490 
(kan) cassette 33 with the flanking regions of bamA was PCR amplified from the genomic 491 
DNA of a ∆rcsF::kan strain (PL339) using primers “bamA Km del F” and “bamA Km 492 
del R”. Then we performed λ-Red recombineering 34 with plasmid pSIM5-tet 35 on the 493 
strain containing pSC270 as a bamA-complementing plasmid in DH300. Deletion of 494 
bamA was verified by PCR. After preparing P1 lysate from this strain, bamA deletion (by 495 
transferring the kan cassette) was performed via P1 phage transduction of the appropriate 496 
strains. 497 
 498 
We performed site-directed mutagenesis to generate bamA variants on plasmids. For 499 
single-codon changes, primer sequences are available upon request; otherwise see 500 
Supplementary Table 5. By using pJH114 as a template and performing site-directed 501 
mutagenesis (SDM), we introduced a six-histidine tag at the N-terminus of BamA. The 502 
C-terminal His-tag of BamE was also removed via SDM, generating pRRA1. The primer 503 
pairs were “SDM-HisBamA F” with “SDM-HisBamA R” and “bamE delHis F” with 504 
“bamE delHis R”. To add bamB next to bamA in pBamA, both bamA and bamB were 505 
PCR amplified as a single DNA fragment from pJH114 36 using primers “pTrc-for” and 506 
“bamB (NotI) R”. The PCR product and pBamA were digested with NcoI and NotI and 507 
then ligated, yielding pBamA-B. pBamAhinge plasmid was generated by SDM using 508 
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primers “BamA hinge F” and “BamA hinge R” and pBamA as template.  To clone bamC, 509 
bamD, and bamE as an operon into a low-copy plasmid (pAM238), PCR was performed 510 
on pRRA1 as a template using primers “bamC kpnI F” and “pTrc-rev2”. The PCR product 511 
and pAM238 were digested with KpnI and XbaI and ligated, generating pSC263. We 512 
cloned bamA without the six-histidine tag into the low-copy plasmid pSC23 10, yielding 513 
pSC270. bamA was PCR amplified from E. coli genomic DNA using primers “BamA 514 
(PciI)F” and “BamA (XbaI)R” and ligated with pSC231 predigested with NcoI and XbaI. 515 
To generate the bamA variants locked in the closed and open conformations, SDM was 516 
performed on pBamA-B. First, the two cysteines in the eL6 loop of BamA were mutated 517 
to serines, generating pBamAL6-B. This plasmid was used as template for SDM to 518 
generate pBamAG393C/G584C-B and pBamAG433C/N805C-B. To generate bamA variants with 519 
amber codons (TAG) to insert 3-(3-methyl-3H-diazirine-3-yl)-propaminocarbonyl-Nε-L-520 
lysine (DiZPK; Artis Chemistry, Shanghai) at selected positions, we performed SDM on 521 
pBamA-B and pSC270; primer sequences are available upon request. 522 
 523 
Expression and purification of the BamAB-RcsF complex 524 
E. coli PL358 cells harboring pJH118 expressing N-terminal six-histidine-tagged BamA 525 
and BamB 36 and pSC216 expressing RcsF 10 were cultured to overexpress BamA, BamB, 526 
and RcsF. Cells were grown in Terrific Broth Auto Inducing Medium (Formedium) 527 
supplemented with 0.2% (w/v) L-arabinose at 37 °C (to induce RcsF), ampicillin (200 528 
µg/mL), and chloramphenicol (25 µg/mL). Cells (1 L) were pelleted when they reached 529 
OD600 ~ 4, re-suspended in cold phosphate-buffered saline (25 mL) containing a protease-530 
inhibitor cocktail (Complete, Roche), and lysed by two passages through a French 531 
pressure cell at 1,500 psi. The cell lysate was centrifuged for 40 min at 40,000 × g and 4 532 
°C. After centrifugation, inner-membrane proteins were solubilized using 0.5% (w/v) N-533 
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lauryl sarcosine (Sigma) in a buffer containing 20 mM Tris-HCl [pH 7.5] and 150 mM 534 
NaCl for 1.5 h at 4 °C on a roller. The suspension was centrifuged for 40 min at 40,000 535 
x g and 4 °C, after which the inner membrane fraction was in the supernatant while the 536 
outer membrane fraction remained in the pellet. Outer-membrane proteins were 537 
solubilized using 1% (w/v) n-dodecyl-β-d-maltopyranoside (DDM; Anatrace) in a buffer 538 
containing 20 mM Tris-HCl [pH 7.5], 300 mM NaCl, and 20 mM imidazole overnight at 539 
4 °C on a roller. After centrifugation (40,000 x g, 4 °C, 40 min), the supernatant was 540 
mixed with Ni-NTA agarose beads (2 mL; IBA Lifescience) equilibrated with 20 mM 541 
Tris-HCl [pH 7.5], 300 mM NaCl, 20 mM imidazole, and 1% (w/v) DDM. After washing 542 
the resin with 10 column volumes of buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 543 
20 mM imidazole, 0.6% (w/v) tetraethylene glycol monooctyl ether (C8E4; Anatrace), 544 
and 0.01% (w/v) DDM), proteins were eluted with 5 column volumes of the same buffer 545 
supplemented with 200 mM imidazole. The eluted complex was then concentrated to 1 546 
mL using a Vivaspin 4 Turbo concentrator (Cut-off 5 kDa; Sartorius). A final purification 547 
step was performed using size-exclusion chromatography by loading the proteins on a 548 
HiLoad 10/300 Superdex 200 column (GE Healthcare) using 20 mM Tris-HCl [pH 7.5], 549 
150 mM NaCl, 0.6% (w/v) C8E4, and 0.01% (w/v) DDM. Peak fractions were pooled 550 
and concentrated to ~30 mg/mL for crystallization. 551 
 552 
For co-crystallization with NaI, NaI replaced NaCl in the gel-filtration buffer. Peak 553 
fractions were pooled and concentrated to ~30 mg/mL using a Vivaspin 4 Turbo 554 
concentrator (Sartorius). 555 
 556 
The Blue native electrophoresis analysis of the concentrated complex was carried out on 557 
a 3-12% Bis-Tris gel (Life Technologies) following the manufacturer’s instructions. The 558 
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protein complex bands separated in the native electrophoresis were identified via SDS-559 
PAGE. Briefly, bands of interest were excised, boiled in SDS-PAGE sample buffer, and 560 
applied to the top of a polyacrylamide gel. 561 
 562 
Expression and purification of BAM (BamABCDE) in complex with RcsF 563 
E. coli BL21 (DE3) was transformed with pRRA1 expressing all five BAM proteins (N-564 
terminal six-histidine-tagged BamA, BamB, BamC, BamD, and BamE) and pSC216 565 
expressing RcsF for BAM and RcsF overexpression. In control cells, only pRRA1 was 566 
transformed. Protein expression and purification were performed as described above 567 
except that the detergent was exchanged to 0.1% (w/v) DDM during Ni-NTA affinity 568 
chromatography and size-exclusion chromatography. Eluted complexes were identified 569 
via SDS-PAGE and concentrated to 4 mg/mL. Blue native electrophoresis of the 570 
concentrated complexes was carried out as described above. 571 
 572 
Crystallization, data collection and structure determination 573 
Crystallization assays were carried out using the hanging drop vapor diffusion method in 574 
48-well plates (Molecular Dimensions) at 20°C. The protein solution was mixed in a 2:1 575 
ratio with the crystallization solution from the reservoir. The best native crystals were 576 
grown after 4 to 5 days in C10 and G10 conditions from Morpheus crystallization screen 577 
(Molecular dimensions; C10: 0.03 M sodium nitrate, 0.03 M sodium phosphate dibasic, 578 
0.03 M ammonium sulfate, 0.10 M Tris-base [pH 8.5]; BICINE, 20 % (v/v) ethylene 579 
glycol; 10 % w/v PEG 8000; G10: 0.02 M sodium formate; 0.02 M ammonium acetate; 580 
0.02 M sodium citrate tribasic dihydrate; 0.02M potassium sodium tartrate tetrahydrate; 581 
0.02 M sodium oxamate; 0.10 M Tris-base [pH 8.5]; BICINE; 20% (v/v) ethylene glycol; 582 
10 % (w/v) PEG 8000).  583 
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 584 
The crystals were harvested in a nylon loop, flash-cooled and stored in liquid nitrogen for 585 
data collection. Crystals were screened on beamlines Proxima-1 and Proxima-2 at 586 
Synchrotron Soleil (Gif-sur-Yvettes, France) as well as beamlines I03 and I04-1 at 587 
Diamond Light Source (Didcot, UK). Data for structure determination were collected on 588 
the Proxima-2 beam-line at Synchrotron Soleil at a wavelength of 1.77 Å. Data were 589 
indexed and integrated using XDS 37, scaled using XSCALE 37 and anisotropically 590 
corrected using STARANISO, applying a high resolution cutoff of I/σI = 1.2 38. The 591 
crystals belong to space group C2, with the unit cell dimensions a=158.84, b=142.5300, 592 
c=116.4200 Å3 and β=102.61°. The structure was determined by molecular replacement 593 
using Phaser 39, with the globular domain of RcsF (residues 51-130, PDB:2Y1B) and the 594 
inward open BamA β-barrel (residues 422-809, PDB: 5D0O) and BamA POTRA domain 595 
4 (residues 265-344; PDB: 5D0O) as search models. Molecular replacement searches 596 
identified two copies each of the BamA β-barrel, RcsF and POTRA domain 4. Following 597 
10 cycles of rigid body refinement POTRA domains 1, 2, 3 and 5 of the first BamA-RcsF 598 
copy in the asymmetric unit (Extended Data Figure 2) could be manually placed in the 599 
2FoFc and FoFc difference density and were subjected to an additional 10 rounds of rigid 600 
body refinement. The model was refined to 3.8 Å resolution using BUSTER 40 and 601 
intermittent manual inspection and correction of the model in Coot 41. BUSTER was run 602 
using Local Structure Similarity Restraints (LSSR) over the two copies in the asymmetric 603 
unit, as well as target-based similarity restraints using the inward open BamA structure 604 
as reported in PDB:5D0O. The final model shows R and freeR factors of 28.3% and 605 
31.4%, respectively, containing 1388 amino acids, of which 19 are indicated as 606 
Ramachandran outliers (1.4%). We note that side chain positioning is frequently 607 
ambiguous at 3.8 Å resolution and should therefore not be over-interpreted by users of 608 
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the deposited model. Side chains for which no unambiguous electron density was 609 
observed were not pruned for ease of model interpretation. Such side chains were 610 
included in refinement and manually modelled in there most likely rotamer using Coot. 611 
Data collection and refinement statistics are found in Supplementary Table 1. 612 
 613 
Site-specific photo-crosslinking 614 
We used a site-specific photo-crosslinking method described previously 10 with some 615 
modifications. To incorporate DiZPK into BamA, we used the pSup-Mb-DIZPK-RS 616 
plasmid encoding an evolved Methanosarcina barkeri pyrrolysyl-tRNA synthetase and 617 
an optimized tRNACUAPyl  suppressor 24. DH300 cells were co-transformed with pSup-Mb-618 
DIZPK-RS and one of the plasmids containing an amber codon in BamA in pSC270. 619 
Cells were grown in 3-(N-morpholino) propanesulfonic acid (MOPS) minimal medium 620 
supplemented with 0.2% glucose, 0.2% (w/v) arabinose, 200 µM IPTG, 0.001% (w/v) 621 
casamino acids, and 0.8 mM DiZPK. When cells reached OD600 = 1, 500-µL samples 622 
were irradiated with ultraviolet light at 365 nm or left unirradiated for 10 min. Cells were 623 
precipitated with trichloroacetic acid, washed with ethanol, and proteins were solubilized 624 
in 100 μL SDS-PAGE sample buffer (50 mM Tris-HCl [pH 7.5], 1% (w/v) SDS, 10% 625 
(v/v) glycerol, 0.002% (w/v) bromophenol blue) before SDS-PAGE and immunoblotting 626 
using anti-RcsF and anti-BamA antibodies. 627 
 628 
In vivo BS3 crosslinking 629 
Cells were harvested around mid-log phase (OD600 = ~ 0.5). In vivo crosslinking was 630 
performed as described previously 10, except that bis(sulfosuccinimidyl)suberate 631 
(CovaChem) was used instead of 3,3’-dithiobis(sulfosuccinimidyl propionate). 632 
  633 
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Chemical crosslinking-mass spectrometry 634 
We first performed buffer exchange of the purified BamAB-RcsF complex using a PD-635 
10 desalting column (GE Healthcare Life Sciences). The complex was eluted with 20 mM 636 
HEPES [pH 7.5], 150 mM NaCl, and 0.1% (w/v) DDM. A 30-fold molar excess of the 637 
crosslinker disuccinimidyl dibutyric urea (50 mM stock solution in dimethyl sulfoxide, 638 
Thermo Scientific) was added to the protein solution and incubated at 37 °C for 1 h. The 639 
reaction was quenched by adding Tris-HCl to a final concentration of 20 mM. Crosslinked 640 
proteins were precipitated with ethanol and trypsinized, and crosslinked peptides were 641 
enriched through cation exchange as described previously 42. Briefly, crosslinked proteins 642 
(50 μL) were precipitated by adding ice-cold ethanol (150 μL) and 3 M sodium acetate 643 
[pH 5.3] (5 μL) prior to incubation at −20 °C for 16 h. The sample was centrifuged 644 
(16,200 x g, 4 °C, 30 min), the supernatant was removed, and the pellet was washed by 645 
adding 80% (v/v) ice-cold ethanol (200 μL) and vortexing for 30 s. The sample was 646 
centrifuged again, the supernatant was removed, and the pellet was dried in a vacuum 647 
centrifuge. The pellet was dissolved in 1% (w/v) RapiGest (Waters) (10 μL) and trypsin 648 
(Sequencing grade, Promega) solution was added (90 μL, 1:50 trypsin:protein mass ratio) 649 
before incubating overnight at 37 °C. Trifluoroacetic acid was added (final concentration 650 
0.5% (v/v)) and the sample was incubated at 37 °C for 1 h to precipitate the Rapigest. The 651 
mixture was centrifuged (16,200 x g, 4 °C, 30 min), the supernatant was concentrated 652 
using a vacuum centrifuge, and the pellet was dissolved in 20% (v/v) acetonitrile/0.4% 653 
(v/v) formic acid (20 μL). Strong cation exchange enrichment was carried out using 654 
OMIX 10 µL strong cation exchange pipette tips (Agilent) as previously described 42. 655 
 656 
Fractionated peptides (5 µL) were injected onto a reverse-phase Acquity M-Class C18, 657 
75 µm x 150 mm column (Waters) and separated via gradient elution of 1-50% (v/v) 658 
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solvent B (0.1 % (v/v) formic acid in acetonitrile) in solvent A (0.1 % (v/v) formic acid 659 
in water) over 60 min at 300 nL/min. The eluate was infused into a Xevo G2-XS (Waters) 660 
mass spectrometer operating in positive ion mode. Mass calibration was performed by 661 
infusion of aqueous NaI (2 µg/µL). [Glu1]-Fibrinopeptide B was used for the lock mass 662 
spray, with a 0.5 s lock spray scan taken every 30 s. The lock mass correction factor was 663 
determined by averaging 10 scans. Data acquisition was performed in DDA mode with a 664 
1 s mass-spectrometry scan over m/z 350-2000. Instrument parameters were optimized 665 
for the detection of crosslinked peptides, as described previously 43. Data processing and 666 
crosslink identification were performed using MeroX 44. 667 
 668 
Expression of BamA mutants and co-purification with RcsF 669 
pBamA and pBamA-B each provide chromosomal-level expression of BamA 10. 670 
Therefore, we introduced mutations of bamA in these plasmids to test the physiological 671 
effects of BamA mutants; plasmids were expressed in the presence or absence of bamA 672 
on the chromosome. Cells (2 mL) were harvested at OD600 ~ 0.5 to purify BamA, except 673 
during the following experiment. The cysteine mutants of BamA, when oxidized to form 674 
a disulfide bond, allow BamA to form an “open” or “closed” lateral gate. Therefore, the 675 
efficiency of disulfide-bond formation in these mutants is very important. To enhance the 676 
oxidation of cysteines to form disulfide bonds, we added 3 mM tetrathionate as an oxidant 677 
45 at OD600 ~ 0.5 and harvested cells (1 mL) at OD600 ~ 1.0. 678 
 679 
Since there was a six-histidine tag at the N-terminus of BamA, we used Dynabeads™ 680 
His-Tag (Invitrogen) for Ni-affinity purification. After resuspending cells in 350 µL of 681 
25 mM Tris-HCl [pH 7.4], 290 mM NaCl, 1 mM imidazole, and 0.05% (w/v) DDM 682 
(buffer A), cells were lysed via mild sonication on ice. Membrane vesicles were further 683 
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solubilized by increasing the DDM concentration to 1% (w/v). After removing debris via 684 
centrifugation at 9,300 × g for 10 min, 5 µL of Dynabeads™ His-Tag (pre-washed with 685 
buffer A and resuspended in the same volume) were added to 250 µL of the supernatant, 686 
which was incubated for 20 min at 4 °C. The rest of the supernatant was used as the input 687 
fraction. The magnetic beads were pulled by a magnet and the supernatant was taken for 688 
the flow-through fraction. After washing the beads three times with 750 µL buffer E using 689 
the magnet, bound proteins were eluted with 83 µL (three times enrichment compared to 690 
the other fractions) of buffer A with 300 mM imidazole. Forty microliters of the input, 691 
flow-through, and elution fractions were mixed with SDS-PAGE sample buffer. After 692 
denaturation of the three fractions, SDS-PAGE was performed, followed by 693 
immunoblotting using rabbit-raised anti-BamA, anti-RcsF 10, anti-BamB, anti-BamC, 694 
anti-BamD, and anti-BamE. 695 
 696 
To determine the redox states of the cysteine-introduced gate mutants of BamA, we added 697 
3 mM N-ethylmaleimide in SDS-PAGE sample buffer to alkylate cysteines to prevent 698 
thiol-disulfide exchange. The sample was divided into two aliquots and 10 mM of tris(2-699 
carboxyethyl) phosphine was added to one of them to obtain the reduced state of BamA 700 
as a control. Nu-PAGE (4-12% gradient; Novex) was used to separate the oxidized and 701 
reduced bands of BamA. 702 
 703 
Spotting assay for growth. Cells were grown in M9 minimal glucose medium at 30°C 704 
until they reached OD600 =1. Tenfold serial dilutions were made in M9 minimal glucose, 705 
plated onto M9 minimal glucose or LB agar, and incubated at 30°C or 37°C. Plates were 706 
supplemented with ampicillin (200 μg/ml). 707 
 708 
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Biolayer interferometry 709 
Untagged BamA was first biotinylated using the EZ-Link NHS-PEG4-biotin kit (Perbio 710 
Science). The reaction was stopped by adding Tris [pH 8] to the final concentration of 20 711 
mM. Excess NHS-PEG4-biotin was removed by passing the sample through a Zeba Spin 712 
Desalting column (Perbio Science). Biolayer interferometry was performed in black 96-713 
well plates (Greiner) at 25 °C using OctetRed96 (ForteBio). Streptavidin and Ni-NTA 714 
biosensor tips (ForteBio) were hydrated with 0.2 mL working buffer (20 mM Tris [pH 715 
8], 150 mM NaCl, 0.03 % (w/v) DDM) and then loaded with biotinylated BamA or 6xHis-716 
tagged RcsF, respectively. 717 
 718 
In the forward experiment, purified 6xHis-tagged RcsF (5 µg/mL) was immobilized on 719 
Ni-NTA sensors until the signal reached 0.5-0.6 nm. Association and dissociation of 720 
BamA to RcsF-coated tips were monitored for 1200 s and 300 s, respectively, by dipping 721 
tips into BamA-containing buffer (serial two-fold dilution from 4000 nM to 62.5 nM), 722 
and subsequently in buffer only. In the reverse experiment, biotinylated BamA was 723 
immobilized on streptavidin sensor tips to a signal of 2.0 nm. The association and 724 
dissociation of RcsF (serial 3-fold dilution from 3000 nM to 12.34 nM) to BamA-coated 725 
tips were monitored for 4800 s and 700 s, respectively. Dissociation constants were 726 
determined using Graphpad Prism by linear regression of the steady-state binding 727 
responses in the saturation binding experiment (Extended Data Fig. 4c, d). 728 
 729 
For binding of the BamAG393C/G584C mutant (Extended Data Fig. 5c), 6xHis-tagged RcsF 730 
was immobilized on Ni-NTA sensors. To follow BamA association and dissociation, 731 
RcsF-coated tips were dipped into 0.2 mL of 200 nM BamA solution, with or without 2 732 
mM diothiothreitol, for 1200 s, followed by 1200 s in buffer only. 733 
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  734 
Antibodies and immunoblotting 735 
Rabbit anti-RcsF antibody was previously generated and used by us 10. We newly raised 736 
the antibodies against BamA, BamB, BamC, BamD, and BamE in rabbits as follows. 737 
Except BamA, the DNA sequences encoding the proteins without the signal sequence 738 
were cloned into pET28a (Novagen) using the NcoI and XhoI restriction sites, which 739 
allows the expressed proteins to be his-tagged at the C-terminus. For BamA, DNA 740 
encoding the POTRA domains (1-4) of BamA with a C-terminal strep-tag (but without 741 
the signal sequence) was cloned in pET21a (Novagen). All the proteins above were 742 
overexpressed in BL21(DE3) and purified using standard methods for Ni-NTA affinity 743 
purification or streptavidin purification (POTRA 1-4). Small aliquots of the purified 744 
proteins were sent to the CER group (Marloie, Belgium) to raise antibodies in rabbits. 745 
Goat Anti-Rabbit IgG alkaline phosphatase conjugated (Sigma) was used as a secondary 746 
antibody at a 1:20,000 dilution. 747 
 748 
Antibody specificity was confirmed by comparing the immunoblot of the wild-type strain 749 
with that of a mutant using each corresponding antibody. The dilutions of the antibodies 750 
for immunoblotting were 1:10,000 (BamA), 1:20,000 (BamB), 1:40.000 (BamC), 751 
1:10,000 (BamD), and 1:20,000 (BamE). The specificity of the antibodies was verified; 752 
data are available upon request. 753 
 754 
To simplify the detection of Bam components and RcsF after purification of BamA, we 755 
used two mixtures of antibodies (anti-BamA plus anti-RcsF; anti-BamB, anti-BamC, anti-756 
BamD, plus anti-BamE). Detection specificity was verified using similar mutants as 757 
above but harboring pBamA. Data are available upon request. 758 
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 759 
The antibody recognizing the transmembrane domain of OmpA is a gift from the 760 
Bernstein laboratory 46. The rabbit polyclonal OmpC antibody was purchased from 761 
EPIGENTEK. The anti-E. coli EF-Tu antibody (mAb 900) was purchased from 762 
HycultBiotech. The Goat anti-mouse IgG conjugated with the Cy3 fluorescent dye was 763 
used as a secondary antibody for EF-Tu (Amersham). 764 
 765 
β-galactosidase assay 766 
Rcs induction was monitored by measuring β-galactosidase activity as described 47. 767 
Briefly, cells harboring PrprA-lacZ at the attB phage lambda site on the chromosome 768 
were diluted 1:100 from overnight cultures in Luria broth (LB), then incubated at 37°C. 769 
Cells were harvested at OD600 = 0.6-1. Twenty microliters of cells were harvested and 770 
incubated with 80 μl of permeabilization solution (60 mM Na2HPO4·2H2O, 40 mM 771 
NaH2PO4·H2O, 10 mM KCl, 1 mM MgSO4·7H2O, 50 mM β-mercaptoethanol) for 30–45 772 
min at room temperature. Then, 600 μl of substrate (1 mg/ml O-nitrophenyl-β-d-773 
galactoside, 50 mM β-mercaptoethanol) were added. The mixture was further incubated 774 
at 30°C for 20-90 min. Seven hundred microliters of 1 M Na2CO3 were added to stop the 775 
reaction, and the optical density was measured at 420 nm. The standardized amount of β-776 
galactosidase activity was reported in Miller units. The ratio of PrprA-lacZ induction was 777 
calculated relative to the basal level in a WT strain. Bar graphs with corresponding 778 
statistical analysis were prepared using Prism 7 (GraphPad Software, Inc.). 779 
 780 
Statistical methods 781 
The significance of differences among bacterial strains was assessed using GraphPad 782 
Prism 8 according to analysis of variance (two ways ANOVA), followed by the 783 
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application of Tukey’s multiple-comparison test. Normality was assessed using the 784 
Shapiro-Wilk test. 785 
 786 
Molecular modeling: protein insertion in the lipid bilayer  787 
The initial simulation system was prepared starting from the BamA-RcsF complex 788 
determined in this work (PDB code 6T1W) with the POTRA1-4 domains removed. 789 
Missing residues and C-terminal residues of BamA and RcsF were completed with 790 
MODELLER v9.22 48 to generate a protein complex containing residues 347-810 for 791 
BamA and 51-134 for RcsF. This complex was preorientated with respect to the 792 
membrane normal (z axis) using the structure 5AYW 6 from the OPM database 793 
(https://opm.phar.umich.edu) 49 as template, then embedded in an asymmetric bilayer to 794 
mimic the E. coli outer membrane using CHARMM-GUI (http://www.charmm-gui.org) 795 
50 and following the protocols described for OmpLA 51 and BamA 52). The inner leaflet 796 
was a mixture of 100 lipids: 75 1-palmitoyl(16:0)-2-palmitoleoyl(16:1 cis-9)-797 
phosphatidylethanolamine (PPPE), 20 1-palmitoyl(16:0)-2-vacenoyl(18:1 cis-11)-798 
phosphatidylglycerol (PVPG), and 5 1,10-palmitoyl-2,20-vacenoyl cardiolipin with a net 799 
charge of –2e (PVCL2), corresponding to a ratio of 15:4:1. The outer leaflet was 800 
composed of 36 LPS (including the lipid A, R1 core and O-antigen polysaccharide 801 
fragments). The equilibration was performed according to the standard protocol from 802 
CHARMM-GUI Membrane Builder, with restraints that were gradually reduced in 6 803 
steps (2.125 ns overall), using CHARMM version 44b1 53. A similar protocol was used 804 
to build a second system, containing the outward-open conformation of BamA (PDB code 805 
5D0Q) 5 with the POTRA1-4 domains removed and the RcsF from 6T1W shifted upwards 806 
on the z axis by 30 Å. 807 
 808 
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Dynamic importance sampling simulations 809 
Dynamic importance sampling (DIMS) uses a biasing with correction approach to 810 
improve the sampling efficiency of rare events. The soft ratcheting algorithm generates 811 
transitions between states using a stochastic approach 54. It should be noted that at any 812 
point of the DIMS simulation the intermediate system is realistic (no force is applied and 813 
the potential function is not modified) and the simulated pathway is always possible, 814 
although it may not be in all cases the lowest energy one. In this work, we carried out 815 
DIMS Langevin dynamics (LD) simulations using CHARMM version 44b1 (collision 816 
frequency of 25.0) starting from the first system and with the second system as target. 817 
The “soft-ratcheting” implemented in DIMS accepts all steps proceeding towards the 818 
desired final state and a fraction of steps away from the target. This fraction is defined by 819 
DIMS-Cartesian for which we used the recommended value of 10−6 55. Two replicas were 820 
simulated, providing similar results, and only the results from the first replica are 821 
presented here. 822 
 823 
Image and video rendering 824 
The pictures representing molecular data were generated using PyMOL version 2.2.0 825 
(Schrödinger LLC, https://pymol.org). The video was generated from the DIMS 826 
simulation (replica 1) using VMD 56.  827 
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LEGENDS TO EXTENDED DATA FIGURES 828 
 829 
Extended Data Figure 1. RcsF can be co-purified with the BAM complex. (a,b,c) Gel 830 
filtration profiles of the affinity-purified BamAB-RcsF, BAM-RcsF and BAM 831 
complexes. The size exclusion chromatography was performed using a HiLoad 10/300 832 
Superdex 200pg. The input and peak fractions were collected and the samples were 833 
analyzed by blue native electrophoresis with Coomassie staining. The migration pattern 834 
of BamABCDE-RcsF (b) was modified compared to BamABCDE (c) upon size exclusion 835 
chromatography (band 8 increases), reflecting the higher instability of the BamABCDE-836 
RcsF complex. n= 4 biologically independent experiments. 837 
 838 
Extended Data Figure 2. Crystal structure of the BamA-RcsF complex. (a, b) Final 839 
2Fo-Fc electron map of the BamA-RcsF complex, shown with a map contour level of 840 
0.08 e-/Å3 (root mean square deviation 1.02 Å). The asymmetric unit of the crystals holds 841 
two BamA-RcsF copies, one revealing interpretable electron density for the full BamA 842 
sequence (a), and a second revealing unambiguous density for POTRA domain 4 only 843 
(b). In the second copy (b), the electron density corresponding to POTRA domains 1, 2, 844 
3, and 5 is too weak to allow unambiguous rigid body placement of the domains. All 845 
descriptions and images in the main text are based on the first copy (a). (c) Overlay of 846 
two BamA-RcsF complexes in the asymmetric unit. The first complex depicts BamA in 847 
gold and RcsF in blue, while these molecules are yellow and light blue, respectively, in 848 
the second complex. In both copies, RcsF makes an average displacement of 4 Å relative 849 
to the BamA β-barrel. (d) Crystal packing of the BamA-RcsF complex viewed along the 850 
a- (left) and c-axis (right). For the first copy of the BamA-RcsF complex in the 851 
asymmetric unit (orange-slate) the conformation of the POTRA domains is stabilized by 852 
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the packing along the b-axis, whilst for the second copy (cyan-slate) only POTRA domain 853 
4 is involved in crystal contacts. In the latter, POTRA 5, 3, 2 and 1 are not in contact with 854 
neighboring molecules and show weak electron density only due to the lack of 855 
conformational stabilization. 856 
 857 
Extended Data Figure 3. Structural dynamics of the BamA POTRA domains. (a, b) 858 
Superimposition of BamA-RcsF (gold and blue, respectively) with the POTRA domains 859 
in the inward-open BamABCDE complex (PDB: 5D0O; light blue) or the outward-open 860 
BamACDE complex (PDB: 5EKQ; green). Complexes are superimposed based on 400 861 
equivalent Cα atoms in the BamAβ-barrel, and shown in side (a) or periplasmic (b) view. 862 
For 5d0o and 5ekq, the accessory Bam subunits and the BamA β-barrel are omitted for 863 
clarity. (c) Periplasmic view of the inward-open BamABCDE complex, showing binding 864 
of the BAM accessory proteins BamB (magenta), BamC (red), BamD (blue), and BamE 865 
(yellow). Pulldown experiments showed that RcsF binds the BamABCDE complex (Fig. 866 
1). In agreement with this observation, structural comparisons reveal that RcsF binding 867 
would not result in direct steric clashes with any BAM accessory protein. However, the 868 
positions of the POTRA domains in the BamA-RcsF and BamABCDE complexes are 869 
markedly different. In the BamA-RcsF complex, POTRA5 makes a 26° outward rotation 870 
to accommodate RcsF (see also Fig. 3), and a reorganization in the joint between POTRA 871 
domains 3 and 2 results in a more extended conformation of the POTRA “arm” and the 872 
projection of POTRA domains 2 and 1 further from the BamA β-barrel, a conformation 873 
not previously reported in available BamA structures. In the BamABCDE complex, 874 
BamD contacts both POTRA5 and the joint of POTRA domains 1 and 2. In the BamA-875 
RcsF complex, POTRA5 and POTRA domains 2 and 1 are too distant to be bridged by 876 
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BamD; binding of BamD to BamA-RcsF therefore requires a conformational change in 877 
the POTRA arm or the dissociation of BamD at either of these two contact points. 878 
 879 
Extended Data Figure 4. Validation of the BamA-RcsF structure. (a) RcsF aminoacid 880 
sequence. The sequence coverage of the XL-MS experiment was about 60% as 881 
highlighted in violet (b) Ribbon diagram of the BamA-RcsF structure. Highlighted 882 
residues show sites mutated to amber for incorporation of the photoreactive lysine analog 883 
DiZPK. Sites that crosslink to RcsF are green, sites that show no crosslinking are 884 
magenta. Mutation of extracellular loop 1 (eL1; red) leads to loss of RcsF binding (see 885 
panel g). BamA sidechains found to crosslink with RcsF by means of the 886 
homobifunctional amine-reactive crosslinker disuccinimidyl dibutyric urea (DSBU) are 887 
shown as sticks and colored cyan. Residue K61 from RcsF, which was found to crosslink 888 
to BamA using DSBU, is shown as a stick and colored orange. The other two RcsF 889 
residues (K42 and K134) that could be crosslinked to BamA are not visible in this 890 
structural model. (c) In vivo photocrosslinking experiment in which cells expressing the 891 
BamA mutants containing DiZPK at the indicated positions were treated (+) or not (-) 892 
with ultraviolet light. Proteins samples were analyzed via SDS-PAGE and immunoblotted 893 
with anti-RcsF or anti-BamA antibodies, showing that the photo-crosslinked complexes 894 
contain BamA and RcsF. n= 3 biologically independent experiment. WT, wild type. (d, 895 
e) Sensorgrams from biolayer interferometry (n=1) (left) and corresponding equilibrium 896 
binding plots (right) of immobilized RcsF titrated with BamA (d) or immobilized BamA 897 
titrated with RcsF (e). (f) The levels of major OMPs are slightly decreased in cells 898 
expressing BamA∆loop1. WT cells harboring the empty plasmid (pAM238) were used as 899 
control and EF-Tu expression levels were analyzed as loading control. n= 3 biologically 900 
independent experiments. (g) Deletion of loop 1 in BamA prevents RcsF from being 901 
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pulled down with BamA. WT cells harboring the empty plasmid (pAM238) were used as 902 
control. n= 3 biologically independent experiments. (h) Overexpression of pBamA∆Loop1 903 
in a bamA deletion strain activates the Rcs system compared to WT. A chromosomal 904 
rprA::lacZ fusion was used to monitor Rcs activity, and specific β-galactosidase activity 905 
was measured from cells at mid-log phase (OD600=0.5). Boxplot with whiskers (median, 906 
first and third percentiles, lower and upper extreme) from minimum to maximum. All 907 
values were normalized to the average activity obtained for WT cells harboring the empty 908 
plasmid (pET3a) obtained from n= 8 biologically independent experiments. WT, wild 909 
type; Kan, kanamycin. 910 
  911 
Extended Data Figure 5. RcsF binds the inward-open conformation of BamA. (a) 912 
Models for the BamAG393C/G584C 5 and BamAG433C/N805C 26 double cysteine mutants, which 913 
are locked in the outward-open or inward-open conformation, respectively, when 914 
oxidized. Mutated cysteines are shown as atom spheres. (b) BamA barrel locking and 915 
RcsF binding. Overexpression of double cysteine mutants pBamAG393C/G584C-B and 916 
BamAG433C/N805C-B in a wild-type strain. RcsF can be co-purified with the BamA β-barrel 917 
locked in the inward-open conformation (BamAG433C/N805C) by a disulfide bond (ox) but 918 
not in the outward-open conformation (BamAG393C/G584C). BamA mutants become 919 
reduced (red) following treatment with tris(2-carboxyethyl) phosphine (TCEP) and 920 
migrate similarly. The oxidized form of BamAG393C/G584C migrates more slowly than wild-921 
type BamA. As a result, two bands are visible for BamA in the input of BamAG393C/G584C, 922 
the lower migrating band corresponding to wild-type BamA expressed from the 923 
chromosome. n= 3 biologically independent experiments.  (c) Sensorgram from biolayer 924 
interferometry of immobilized RcsF titrated with BamAG393C/G584C, without (oxidized; - 925 
DTT) or with dithiothreitol (reduced; + DTT). When the β-barrel is locked in the outward-926 
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open conformation (-DTT), RcsF is unable to bind BamA. When reduced, 927 
BamAG393C/G584C regains binding, demonstrating that BamA reverts to the inward-open 928 
conformation in which it can bind RcsF. 929 
 930 
Extended Data Figure 6. The movement of POTRA5 towards the periplasmic exit 931 
of the lumen of the BamA barrel could push RcsF upwards. (a, b) Lateral view of the 932 
initial and final conformations, respectively, of the BamA-RcsF complex during the 933 
dynamic importance sampling simulation (DIMS) of the BamA-RcsF complex. (c, d) 934 
Bottom view (from the periplasm) of the above conformations. BamA and RcsF are 935 
colored in orange and blue, respectively. The initial conformation of the system (BamA 936 
and RcsF) corresponds to the structure determined in this work (PDB code 6T1W) 5 with 937 
the POTRA1-4 domains removed. The final conformation of BamA is similar to the 938 
outward-open structure (PDB code 5D0Q). The explicit outer membrane and solvent are 939 
not shown for clarity. (e) Expression from BamAhinge from a plasmid in ∆bamA cells leads 940 
to a severe growth defect when cells are grown at 37°C in rich media, but not when they 941 
are grown in minimal media at 30°C. Cells were grown in M9 minimal glucose medium 942 
at 30°C until they reached OD600 =1. Tenfold serial dilutions were made in M9 minimal 943 
glucose, plated onto M9 minimal glucose or LB agar, and incubated at 30°C or 37°C. 944 
Plates were supplemented with ampicillin (200 μg/ml). n=3 biologically independent 945 
experiments.  946 
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Supplementary Table 1. Data collection and refinement statistics. 
 
 BamA-RcsF 
Data collection  
Space group C2 
Cell dimensions    
    a, b, c (Å) 158.84, 142.53, 116.42 
    α, β, γ  (°)  90.0, 102.6, 90.0 
Resolution (Å)** 48.6 – 3.8 (4.0 – 3.8) * 
Rpim 0.02 (0.79) 
I / σI 15.9 (0.8) 
Completeness (%)  
     Spherical 
     Elliptical** 
Redundancy 







Resolution (Å) 48.6 – 3.8 
No. reflections 18489 
Rwork / Rfree 28.1 / 31.7 
No. atoms  
    Protein 10838 
    Ligand/ion NA 
    Water NA 
B-factors (Å2)  
    Protein 193.5 
    Ligand/ion NA 
    Water NA 
R.m.s. deviations  
    Bond lengths (Å) 0.01 
    Bond angles (°) 1.15 
*Values in parentheses are for highest-resolution shell.  
** Elliptical diffraction limits and principal reciprocal axes of the fitted ellipsoid: 4.6 Å along 0.987 a* - 
0.158 c*, 4.4 Å along b* and 3.8 Å along c* 
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Supplementary Table 2. Intermolecular BamA-RcsF crosslinks detected. 





BamA Peptide RcsF Peptide 
PSMs POTRA Sequence Start End Sequence Start End 
310 61 KLLGR 310 314 IYTNAEELVGKPFR 51 64 3 4 
361 42 FEGNDTSKDAVLR 354 366 AEPAKPKAPR 36 45 3 5 
361 61 FEGNDTSKDAVLR 354 366 IYTNAEELVGKPFR 51 64 78 5 
310 134 KLLGR 310 314 QAVCIGSALNITAK 121 134 1 4 
417 61 VPGSPDQVDVVYKVK 405 419 IYTNAEELVGKPFR 51 64 14 5 
419 61 VKER 418 421 IYTNAEELVGKPFR 51 64 24 5 
N.B. Residue 134 is the C-terminal Lys of RscF 
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Supplementary Table 3. Strains used in this study. 
 
Strains Genotype and description Source  
BL21 
(DE3) 
F- ompT hsdSB (rB- mB-) gal dcm (DE3) Novagen 
DH300 rprA-lacZ MG1655 (argF-lac) U169 32 
PL339 ΔrcsF::kan 10 






RRA73 BL21 (DE3) with pRRA1 This study 
RRA74 BL21 (DE3) with pRRA1 and pSC216 This study 
SEN1071 PL358 with pJH118 and pSC216 This study 
SEN1472 DH300 ∆bamA::kan with pSC270 This study 
SEN1603 DH300 ∆bamA::kan with pBamA This study 
SEN1607 DH300 ∆bamA::kan with pBamA∆loop1 This study 
SEN1411 DH300 with pET3a and pAM238 This study 
SEN991 DH300 with pBamA and pAM238 This study 
SEN1597 DH300 with pBamA-B and pAM238 This study 
SEN1598 DH300 with pBamA-B and pSC263 This study 
RRA54 DH300 with pBamAG393C/G584C-B and pAM238 This study 
RRA106 DH300 with pBamAG433C/N805C-B and pAM238 This study 
SEN1723 DH300 ∆bamA::kan with pBamAhinge This study 
1 
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Supplementary Table 4. Plasmids used in this study. 
Plasmids  Features Source  
pAM238 IPTG-regulated Plac, pSC101-based, 
spectinomycin  
57 
pBAD33  Arabinose regulation, pACYC184-based, 
chloramphenicol  
58 
pSC231 pAM238 with LacIq and the modified Ptrc 10 
pSIM5-tet pSC101-based, repAts, tetracycline 35 
pSUPAR-Mb-Dizpk-
RS 
PylRS, tRNACUAPyl  opt, p15A origin, 
chloramphenicol 
24 
pET3a T7 promoter, ampicillin Novagen 
pTrc99a IPTG-regulated Ptrc, ampicillin 59 
pBamA pET23a with BamAss-6xHis-2xAla-
BamA(E22-W810), Ampicillin 
10 
pBamAhinge pBamA (BamA with the insertion of a LVPR 
sequence at position 424)  
This study 
pBamA∆loop1 pBamA (BamA with the deletion from T434-
G437) 
This study 
pBamA-B pBamA::BamB This study 
pBamAG393C/G584C-B pBamAL6-B with BamAG393C/G584C This study 
pBamAG433C/N805C-B pBamAL6-B with BamAG433C/N805C This study 
pSC263 pAM238 with BamCDE, spectomycin This Study 




pJH118 pTrc99a::6×His-BamA-BamB 36 
pRRA1 pJH114 but with modifications: 6×His-BamA 
and BamE with no 6×His 
This study 
pSC270 pSC231 with BamA This study 
pSC270 R583X amber codon (TAG) replacing the codon for 
the designated amino acid residues 
This study 
pSC270 R592X amber codon (TAG) replacing the codon for 
the designated amino acid residues 
This study 
pSC270 R598X amber codon (TAG) replacing the codon for 
the designated amino acid residues 
This study 
pSC270 R610X amber codon (TAG) replacing the codon for 
the designated amino acid residues 
This study 
pSC270 R632X amber codon (TAG) replacing the codon for 
the designated amino acid residues 
This study 
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pSC270 R634X amber codon (TAG) replacing the codon for 
the designated amino acid residues 
This study 
pSC270 R661X amber codon (TAG) replacing the codon for 
the designated amino acid residues 
This study 
pSC270 K808X amber codon (TAG) replacing the codon for 












































Supplementary Table 5. Primers used in this study. 
 
Name Sequence (5’ to 3’) 
bamB (NotI) R GAGAGCGGCCGCTTAACGTGTAATAGAG 
pTrc-for CAAGGCGCACTCCCGTTCTGG 
pTrc-rev2 CGCCAGGCAAATTCTG 
BamA (PciI)F GAGACATGTTGGCGATGAAAAAGTTGC 
BamA (XbaI)R GAGTCTAGATTACCAGGTTTTACCG 
bamC kpnI F GATCGGTACCTCGGATCTTAGGGAGATTTGATGGC 
bamA Km del F GATTTCTCTCGGTTATGAGAGTTAGTTAGGAAGAACG
CATAATAACGATGATTCCGGGGATCCGTCGACC 






bamE delHis F TGCGCTGAGTGGTAACTAAGATCCTCTAGAGTCGAC 
bamE delHis R GTCGACTCTAGAGGATCTTAGTTACCACTCAGCGCA 
BamA Hinge F GTAAAAGAGCGCAACACCCTGGTGCCGCGCGGTAGC
TTCAACTTTGGT 













Supplementary Video 3 
Dynamic importance sampling (DIMS) simulation of the BamA-RcsF complex 4 
reproducing the proposed push-and-pull model. The simulation shows the transition 5 
of BamA from the inward-open to the outward-open conformation, with the POTRA5 6 
domain moving towards the periplasmic exit of the lumen and pushing RcsF upwards. 7 
This movement is accompanied later on by the movement of strands 1-6 in BamA (Z1 8 
domain) and the opening of the outward-facing extremity. The initial conformation of the 9 
system (BamA and RcsF) corresponds to the inward-open structure determined in this 10 
work (PDB code 6T1W) with the POTRA1-4 domains removed. The final conformation 11 
of BamA is similar to the outward-open structure (PDB code 5D0Q). The proteins are 12 
represented as cartoons (BamA and RcsF colored in orange and blue, respectively), the 13 
explicit outer membrane represented as sticks and the oxygen atoms of water molecules 14 
represented as red dots. 15 
 16 
 
 
 
 
 
 
 
